Product Information
GABAPENTIN 600 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0668 per EA under NDC 64380072701. Its NADAC has been published 28 times since Dec 17, 2025.
Strength
600 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380072701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA203244On Market Since
11/10/2025
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 600 MG TABLET has been published 28 times since Dec 17, 2025, and over the history we have for it it has declined 2.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0668 per EA |
|---|---|
| All-time high | $0.0692 (May 13, 2026) |
| All-time low | $0.0668 (Jun 17, 2026) |
| 52-week high | $0.0692 |
| 52-week low | $0.0668 |
| Median price | $0.0687 |
| Average price | $0.0686 |
| Largest weekly change | -2.1% (Jun 17, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 22 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 600 MG TABLET, manufactured by Strides Pharma Inc., is $0.0668 per EA (NDC 64380072701), effective Jun 24, 2026.
How has the price of GABAPENTIN 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 600 MG TABLET has declined 2.7%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 600 MG TABLET?
Since Dec 17, 2025, the NADAC for GABAPENTIN 600 MG TABLET has ranged from a low of $0.0668 (Jun 17, 2026) to a high of $0.0692 (May 13, 2026), with a median of $0.0687 per EA.
Are there cheaper alternatives to GABAPENTIN 600 MG TABLET?
22 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 600 MG TABLET, but none are currently priced below it.
Who manufactures GABAPENTIN 600 MG TABLET?
GABAPENTIN 600 MG TABLET (NDC 64380072701) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification